Arthroplasty-related infection: Incidence, risk factors, clinical features, and outcome;Infecciones relacionadas con las prótesis articulares: Incidencia, factores de riesgo, características clínicas y pronóstico

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 10, 2008, Pages 614-620

  Rodríguez Baño, Jesús ^a   Del Toro, María Dolores ^a   Lupión, Carmen ^a   Suárez, Ana Isabel ^a   Silva, Luis ^a   Nieto, Isabel ^a   Muniain, Miguel Ángel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Arthroplasty; Joint prosthesis implantation; Prosthesis related infection; Risk factors; Surgical wound infection

Indexed keywords

ANTIINFECTIVE AGENT;

ARTHROPLASTY; ARTICLE; CONTROLLED STUDY; HEALTH SURVEY; HIP ARTHROPLASTY; HOSPITAL INFECTION; HUMAN; INCIDENCE; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; RISK FACTOR; SURGICAL INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COMBINED MODALITY THERAPY; COMORBIDITY; CROSS INFECTION; DEBRIDEMENT; DEVICE REMOVAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SPAIN; SURGICAL WOUND INFECTION; URINARY CATHETERIZATION;

EID: 58149476157     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/s0213-005x(08)75277-7     Document Type: Article

References (32)

1. Widmer AF. New developments on diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001;33 Suppl 2:S94-106.
2. Azanza JR. ¿Cuál es el coste de una infección de prótesis? Enferm Infecc Microbiol Clin. 2001;19:43-5.
3. NIH consensus development panel on total hip replacement. NIH Consensus Conference: total hip replacement. JAMA. 1995;273:1950-6.
4. Harris WH, Sledge CB. Total hip and total knee replacement. N Engl J Med. 1990;323:801-7.
5. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br. 2005;87:844-50.
6. Gómez J, Rodríguez M, Baños V, Martínez L, Claver MA, Ruiz J, et al. Infección de prótesis articulares: epidemiología y clínica. Estudio prospectivo 1992-1999. Enferm Infecc Microbiol Clin. 2002;20:74-7.
7. García-Pont J, Blanch-Falp J, Coll-Colell R, Rosell-Abaurrea F, Tapiz-Reula A, Dorca-Badía E, et al. Infección de prótesis articulares: estudio prospectivo en 5 hospitales de Cataluña. Enferm Infecc Microbiol Clin. 2006;24:157-61.
8. Jover-Sáenz A, Barcenilla-Gaite F, Torres-Puig-Gross J, Prats-Gispert L, Garrido-Calvo S, Porcel-Pérez JM. Factores de riesgo de infección de prótesis total articular: estudio de casos y controles. Med Clin (Barc). 2007;128:493-4.
9. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247-54.
10. Minnema B, Vearncombe M, Augustin A, Gollish J, Simor AE. Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol. 2004;25:477-80.
11. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-54.
12. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother. 2004;53:127-9.
13. Gómez J, Rodríguez M, Baños V, Martínez L, Claver MA, Ruiz J, et al. Infección de implantes osteoarticulares: factores pronósticos e influencia del tratamiento antibiótico prolongado en su evolución. Estudio prospectivo, 1992-1999. Enferm Infecc Microbiol Clin. 2003;21:232-6.
14. Salavert M, Martínez J, Sánchez C, Matamala A, Pons M, Anglés S, et al. Infección de prótesis de cadera: aproximación diagnóstica y tratamiento de 27 episodios. Enferm Infecc Microbiol Clin. 1994;12:490-6.
15. Servicio de Protocolos Asistenciales, Servicio Andaluz de Salud. Plan de vigilancia y control de las infecciones nosocomiales en los hospitales del Servicio Andaluz de Salud. 2002. [Consultada el 10 de agosto de 2007]. Disponible en: http://saei.org/hemero/consensos/plan-in-archivos/plan-in.pdf
16. Garner JS, Jarvis WR, Emorl TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40.
17. Horan TC, Gaynes RP, Martone WJ, Jarcis WR, Emori TG. CDC definitions of nosocomial surgical suite infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606-8.
18. Emori TG, Culver DH, Horan TC, Jarvis WR, White JW, Olson DR, et al. National Nosocomial Surveillance System (NNIS): description of surveillance methods. Am J Infect Control. 1991;19:19-35.
19. Tsukuyama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78-A:512-23.
20. Gustafson TL. Practical risk-adjusted quality control charts for infection control. Am J Infect Control. 2000;28:406-14.
21. Monge Jodrá V, Díaz-Agero Pérez C, Sainz de los Terreros Soler L, Saa Requejo CM, Dacosta Ballesteros D, and the Quality Control Indicator Working Group. Results of the Spanish national nosocomial infection surveillance network (VICONOS) for surgery patients from January 1997 throughout December 2003. Am J Infect Control. 2006;34:134-41.
22. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-85.
23. Platt R. Toward better benchmarking. Infect Control Hosp Epidemiol. 2005;26:433-4.
24. Moro ML, Morsillo F, Tangenti M, Mongardi M, Pirazzini MC, Ragni P; ICN Regional Group. Rates of surgical-site infection: an international comparison. Infect Control Hosp Epidemiol. 2005;26:442-8.
25. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res. 1984;182:117-26.
26. Gordon SM, Culver DH, Simmons BP, Jarvis WR. Risk factors for wound infections after total knee arthroplasty. Am J Epidemiol. 1990;131:905-16.
27. Lazzarini L, Pellizzer G, Stecca C, Viola R, de Lalla F. Postoperative infections following total knee replacement: an epidemiological study. J Chemother. 2001;13:182-7.
28. Pessaux P, Atallah D, Lermite E, Msika S, Hay JM, Flamant Y, et al. Risk factors for prediction of surgical site infections in "clean surgery". Am J Infect Control. 2005;33:292-8.
29. Gordon SM, Culver DH, Simmons BP, Jarvis WR. Risk factors for wound infections after total knee arthroplasty. Am J Epidemiol. 1990;131:905-16.
30. Keating MR, Steckelberg JM. Orthopedic prosthesis salvage. Clin Infect Dis. 1999;29:296-7.
31. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE, for the Foreign-Body Infection (FBI) Study Group. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomised controlled trial. JAMA. 1998;279:1537-41.
32. Soriano A, García S, Bori G, Almela M, Gallart X, Macule F, et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect. 2006;12:930-3.